ALRN — Aileron Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Aileron Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	18.3	13.8	45.9	21.2	17.3
Prepaid Expenses
Total Other Current Assets
Total Current Assets	19.6	16.3	48.2	21.9	18.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6.36	0.015	0.28	0.11	0.019
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	26.5	16.3	48.5	22	106
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	5.84	3.96	4.51	3.38	4.38
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	10.4	4.18	4.58	3.38	7.71
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	16	12.2	43.9	18.6	98.3
Total Liabilities & Shareholders' Equity	26.5	16.3	48.5	22	106
Total Common Shares Outstanding
Total Preferred Shares Outstanding